LEP and breast carcinoma: Indeed, we found recently a close relationship between estrogen and the leptin pathway and a stimulatory effect of leptin on the in vitro tumor expression of aromatase [29], [37] and these results suggest leptin could adverse effects on the efficacy of breast cancer treatment, particularly anti-estrogen treatments such as tamoxifen.